STAAR Surgical Company to be acquired by Alcon Inc. in USD 1.5bn all-cash transaction

On August 4, 2025, STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the proprietary Implantable Collamer® Lens for vision correction, entered into a definitive merger agreement to be acquired by Alcon (SIX/NYSE: ALC) in an all-cash transaction for approximately $1.5 billion.

Niederer Kraft Frey served as Swiss legal advisor to STAAR Surgical Company.

The NKF team comprises Philipp Haas and Julia Tolstova (both Corporate/M&A) and Jacques Pittet and Morgan Boeffard (both Tax).